Webisodes
Risk and Reward: Navigating REMS pitfalls to position brands for success
Risk evaluation and mitigation strategies (REMS) hold the potential to cause anxiety around everything from prescribing processes and patient adherence to payer relations and patient access. At the same time, REMS could translate to strategic opportunities for companies that handle them correctly. Terri Madison, vice president of epidemiology and risk management for Xcenda, joins the program to detail how changes in REMS will require changes in how manufacturers approach their specialty product strategy.
(0 Comments)
Date:
August 31, 2010
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Peyton Howell
President, Consulting Services & Health Policy
AmerisourceBergen
Specialty Group
Terri Madison
Vice President, Epidemiology and Risk Management
Xcenda
Expanded Impact of Specialty Pharmacies on Pharma, Providers, Patients and Payers
Collaboration between specialty pharmacies, healthcare providers, payers and patients has grown substantially in recent years--but what further enhancements can be made? Craig Miller, Vice President of Business Development for US Bioservices, joins us to provide his thoughts on the expanding role that specialty pharmacies play in the care delivery process. He discusses how new technologies and services in the pharmacy industry can create efficiencies and value even outside the pharmacy environment. Specifically, he addresses how tools like prescriber portals and high touch reimbursement and adherence programs can reduce administrative burden for physicians, improve product adherence rates for pharma and reduce variability of care of payers.
(0 Comments)
Date:
August 6, 2010
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Craig Miller
Vice President of Business Development
US Bioservices
Policy and Providers: New Legislation's Effect on Physician Practices
Health policy expert Peyton Howell rejoins "In the Know" to detail how recent legislation will impact specialty care providers. View our discussion on what immediate advantages might come from recent policy changes, and what longer terms efforts might arise from expanding health benefits to so many more Americans. Ms. Howell also dives into key provider issues like the latest in REMS requirements, the government's role in technology adoption within practices and 340B in the oncology market.
(0 Comments)
Date:
July 16, 2010
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Peyton Howell
President, Consulting Services & Health Policy
AmerisourceBergen
Specialty Group
Health Policy Changes: What Continues to Keep Pharma Up at Night?
With the finer details of health reform now taking shape, health policy expert Peyton Howell joins "In the Know" to discuss the impact on pharmaceutical and biotech manufacturers. Ms. Howell offers insight into how the mid-term elections might play into the pharma community's strategic decision-making, as well as why changes to issues like 340B pricing and Medicare physician reimbursement hold significant potential to disrupt "business as usual" in the delivery of healthcare.
(0 Comments)
Date:
July 6, 2010
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Peyton Howell
President, Consulting Services & Health Policy
AmerisourceBergen
Specialty Group
Clinical Pathways and Other Cost-efficiency Initiatives Impacting Cancer Care (Part 2)
In the second of our two-part webisode, Oncology Physician Resource's Lesli Lord rejoins us to tell what steps oncology practices are taking to implement clinical pathways and ensure compliance. She brings up the practical balance between the cost and quality of care, as it relates to pathway development. And she discusses how practice technologies-like electronic medical records-combine with proper workflow to aggregate and output the data required by the payer community.
(0 Comments)
Date:
June 2, 2010
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Lesli Lord
Executive Director
Oncology Physician Resource
Clinical Pathways and Other Cost-efficiency Initiatives Impacting Cancer Care (Part 1)
Explore how the economics of cancer care have changed and what practices are doing to maintain financial viability, without reducing the quality of patient care. Lesli Lord, executive director for Oncology Physician Resource, joins us for part one of our two-part webisode to discuss how initiatives like clinical pathways can create win-win situations for oncology practices, payers--as well as manufacturers. She also dives into the impact that generic alternatives might have on a practice's ability to drive cost efficiencies.
(0 Comments)
Date:
May 18, 2010
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Lesli Lord
Executive Director
Oncology Physician Resource
Provider-facing Technologies' Impact on Pharma's Success
Traditionally, healthcare has been viewed as lagging behind other industries when it comes to technology innovation and adoption. But with technologies like electronic medical records and e-prescribing growing in popularity, this image may be changing-and with that change comes new opportunities for providers, patients, payers and pharma. Dale Danilewitz, chief information officer for AmerisourceBergen Specialty Group, and Neil Herson, president for ASD Healthcare, join In the Know to discuss how broader adoption of provider-facing technologies can help facilitate improved data aggregation, clinical analysis and product planning. They also dive into the effect that general consumer electronic trends have had in patient expectations and provider behavior.
(0 Comments)
Date:
May 3, 2010
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Dale Danilewitz
Chief Information Officer
AmerisourceBergen
Specialty Group
Neil Herson
President
ASD Healthcare
Commercialization Best Practices from Small and Mid-sized Pharma
Issues like health policy changes and industry consolidation have impacted the entire pharmaceutical market, but small and mid-sized pharmaceutical companies have responded to these issues in a different-and often more nimble-way. Doug Cook, vice president of operations for ICS, joins In the Know to explore the unique mindset that many smaller pharmaceutical companies have as they approach commercialization decisions around logistics, regulatory compliance and data requirements. He also discusses what larger manufacturers might learn from small pharma's best practices.
(0 Comments)
Date:
April 19, 2010
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Doug Cook
Vice President, Operations
ICS
Patient Assistance Programs in the New Decade: Analysis & Best Practices for Pharmaceutical Manufacturers
Find out how pharmaceutical manufacturers may be adjusting their approach to patient assistance and co-pay assistance programs in response to the global economic recession, the increase of uninsured and underinsured populations, as well as potential changes in U.S. health policy. Nancy McGee, chief operating officer for Lash Group, joins In the Know to discuss how patient assistance programs have changed in recent years--as well as what manufacturers can continue to do to ensure appropriate access to their products in the years to come.
(0 Comments)
Date:
March 17, 2010
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Nancy McGee
Chief Operating Officer
Lash Group
Health Reform & Pharma: What Happens Next?
Noted healthcare policy expert Peyton Howell rejoins In the Know for an update on the viability of healthcare reform. She discusses how recent changes will impact manufacturers, patients and providers-as well as what manufacturers can be doing now in the wake of continued uncertainty.
(0 Comments)
Date:
March 3, 2010
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Peyton Howell
President, Consulting Services & Health Policy
AmerisourceBergen
Specialty Group
One-on-one with Oncology Business Review: Examining the Present and Future of Cancer Care
Oncology Business Review Founder and Publisher Don Sharpe joins In the Know for a candid discussion where the interviewer becomes the interviewee. Don offers his thoughts on the positive trends in the oncology market that many people seem to have forgotten, as well as the negatives that can't be ignored. He weighs in on the cost v. quality debate in cancer care and provides recommendations on what manufacturers can do to increase the real and perceived value of their products.
(0 Comments)
Date:
February 22, 2010
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Don Sharpe
Founder and Publisher
Oncology Business Review
Supply Chain v. Value Chain: Evaluating the Role that Distributors and Specialty Pharmacies Play in Product Success
Learn how relationships between distributors, specialty pharmacies and manufacturers are changing--motivated in part by manufacturers' need for more detailed reporting data and more robust clinical services. Neil Herson, President of ASD Healthcare, and Mark Johnson, President of US Bioservices, discuss how manufacturer expectations of distributors and specialty pharmacies have changed over the years and what organizations like theirs are doing to drive specialty product growth.
(0 Comments)
Date:
February 12, 2010
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Neil Herson
President
ASD Healthcare
Mark Johnson
President
US Bioservices
Patient Adherence as a Growth Strategy: Rethinking How Adherence Affects Market Share
View our discussion on the increasing role that patient adherence programs are having on the success of specialty pharmaceutical products. Jan Nielsen, vice president of clinical services for ICS, covers how regulatory changes--like REMS--have affected the development of adherence programs; the role that providers, pharmacies and new technologies play in therapy adherence; as well as benchmarking processes that manufacturers are using to measure program success.
(0 Comments)
Date:
February 1, 2010
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Jan Nielsen
Vice President of Clinical Services
ICS
Managed Care's Mindset: How Payers and PBMs Are Approaching the Specialty Space
Explore how managed care companies are working to provide appropriate access to specialty pharmaceuticals--while also working to ensure overall cost-efficiency. Gary Rice, director of specialty clinical management at MedImpact, discusses how the managed care industry is approaching the "cost vs. value" debate, increased interaction between payers, pharma and providers, as well as hot-button issues like biosimilars and comparative effectiveness.
(0 Comments)
Date:
January 22, 2010
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Gary Rice
Director of Specialty Clinical Management
MedImpact
Clarity on Comparative Effectiveness: How and When Will It Be Used by Payers
Gain insight on how comparative effectiveness may be rolled out in the United States, how it will differ from models in Europe and Canada and what other utilization management initiatives may be on the horizon. Bob Mauch, president of Xcenda, discusses this and what pharma can do to ensure continued product success and patient access to medications.
(0 Comments)
Date:
January 6, 2010
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Bob Mauch
President
Xcenda
Managing Managed Care: Changing Relationships between Payers, Pharma and Providers
Learn how payers have forced a change in pharma's approach to launching and commercializing their products. Bob Mauch, president of Xcenda, discusses how pharma companies can address changes in product value messaging, interactions among pharma and payers, as well as potential game-changers like comparative effectiveness to drive product success.
(0 Comments)
Date:
December 14, 2009
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Bob Mauch
President
Xcenda
Oncology Outlook: Real-world Insight from Inside a Practice
Learn how community oncology is responding to declining reimbursement, health policy changes and changing expectations from managed care. Alana Vaughn, practice administrator for Louisiana Hematology Oncology Associates, and Bobby Pope, vice president of sales for ION, also discuss the impact that new practice efficiency tools and new oral oncology products are having on the delivery of cancer care.
(0 Comments)
Date:
December 4, 2009
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Alana Vaughn
Practice Administrator
Louisiana Hematology Oncology Associates
Bobby Pope
Vice President, Sales
ION
Top Five Health Reform Issues that Pharma Needs to Monitor
Learn the five key health reform issues that are poised to impact pharmaceutical manufacturers-as well as the challenges and opportunities these issues represent.
(0 Comments)
Date:
October 29, 2009
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Peyton Howell
President, Consulting Services & Health Policy
AmerisourceBergen
Specialty Group
Using Informatics for More Informed Product Decisions
A closer look at the impact that accurate and timely product data can have on a product's success.
(0 Comments)
Date:
October 9, 2009
Host:
Gina Clark
Senior Vice President
AmerisourceBergen
Specialty Group
Guest:
Matt Johnson
Vice President, Strategy
AmerisourceBergen
Specialty Group
Cory Shouse
Director, Enterprise Business Intelligence
AmerisourceBergen
Specialty Group